1. Home
  2. KROS vs KRT Comparison

KROS vs KRT Comparison

Compare KROS & KRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • KRT
  • Stock Information
  • Founded
  • KROS 2015
  • KRT 2000
  • Country
  • KROS United States
  • KRT United States
  • Employees
  • KROS N/A
  • KRT N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • KRT Plastic Products
  • Sector
  • KROS Health Care
  • KRT Industrials
  • Exchange
  • KROS Nasdaq
  • KRT Nasdaq
  • Market Cap
  • KROS 558.9M
  • KRT 584.8M
  • IPO Year
  • KROS 2020
  • KRT 2021
  • Fundamental
  • Price
  • KROS $14.28
  • KRT $28.27
  • Analyst Decision
  • KROS Buy
  • KRT Buy
  • Analyst Count
  • KROS 13
  • KRT 3
  • Target Price
  • KROS $20.63
  • KRT $33.50
  • AVG Volume (30 Days)
  • KROS 467.7K
  • KRT 98.2K
  • Earning Date
  • KROS 08-06-2025
  • KRT 08-07-2025
  • Dividend Yield
  • KROS N/A
  • KRT 6.81%
  • EPS Growth
  • KROS N/A
  • KRT 0.84
  • EPS
  • KROS 0.11
  • KRT 1.50
  • Revenue
  • KROS $214,713,000.00
  • KRT $430,644,000.00
  • Revenue This Year
  • KROS $5,006.76
  • KRT $10.72
  • Revenue Next Year
  • KROS N/A
  • KRT $6.50
  • P/E Ratio
  • KROS $131.15
  • KRT $19.09
  • Revenue Growth
  • KROS 91657.70
  • KRT 6.21
  • 52 Week Low
  • KROS $9.12
  • KRT $23.00
  • 52 Week High
  • KROS $72.37
  • KRT $33.89
  • Technical
  • Relative Strength Index (RSI)
  • KROS 63.37
  • KRT 49.80
  • Support Level
  • KROS $13.26
  • KRT $28.39
  • Resistance Level
  • KROS $14.83
  • KRT $29.85
  • Average True Range (ATR)
  • KROS 0.40
  • KRT 0.71
  • MACD
  • KROS 0.13
  • KRT 0.10
  • Stochastic Oscillator
  • KROS 79.87
  • KRT 57.83

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About KRT Karat Packaging Inc.

Karat Packaging Inc is engaged in the manufacturing and distribution of disposable products used in restaurants and food service settings. The company operates and evaluates its business as a single reportable segment which encompasses the manufacturing and distribution of a diverse range of single-use food and beverage service products made from materials such as plastic, paper, biopolymer-based, and other compostable forms. The company offers products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery, and straws. These products are available in plastic, paper, biopolymer-based and other compostable forms. Its product line includes a variety of brands such as Tea Zone, Karat, Karat Earth, and Total Clean.

Share on Social Networks: